The evaluation of complete blood count ratios in children with 2019
novel coronavirus (2019‐ncov) infection

Çetin, Ceren; Çağ, Yakup; Uzunoglu, Ilknur; AKIN, YASEMIN; Yilmaz, Sema; İNANDIKLIOĞLU, NİHAL; karaaslan, ayşe

doi:10.5455/medscience.2021.08.246

The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection

Sema YİLMAZ, (Uşak Üniversitesi, Tıp Fakültesi, Çocuk Hematoloji ve Onkoloji Anabilim Dalı, Uşak, Türkiye)

İlknur UZUNOĞLU, (Kartal Dr. Lütfi Kırdar Şehir Hastanesi, Sağlık Bilimleri Üniversitesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, İstanbul, Türkiye)

Nihal İNANDIKLIOĞLU, (Yozgat Bozok Üniversitesi Tıp Fakültesi Tıbbi Biyoloji Anabilim Dalı, Yozgat, Türkiye)

Yakup ÇAĞ, (Kartal Dr. Lütfi Kırdar Şehir Hastanesi, Sağlık Bilimleri Üniversitesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, İstanbul, Türkiye)

Ayşe KARAARSLAN, (Kartal Dr. Lütfi Kırdar Şehir Hastanesi, Sağlık Bilimleri Üniversitesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, İstanbul, Türkiye)

Ceren ÇETİN, (Kartal Dr. Lütfi Kırdar Şehir Hastanesi, Sağlık Bilimleri Üniversitesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, İstanbul, Türkiye)

Yasemin AKIN (Kartal Dr. Lütfi Kırdar Şehir Hastanesi, Sağlık Bilimleri Üniversitesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, İstanbul, Türkiye)

Medicine Science

0 0

Yıl: 2022 Cilt: 11 Sayı: 1 Sayfa Aralığı: 214 - 219 Metin Dili: İngilizce DOI: 10.5455/medscience.2021.08.246 İndeks Tarihi: 21-06-2022

The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection

Öz:

We investigated hematological parameters included WBC, neutrophil, lymphocyte, monocyte, eosinophil, basophil and platelet count. Moreover, we evaluated hematological ratios such as NLR, MLR, ELR, BLR, PLR and MPV/PC. Two groups were classified as positive RT-PCR with bilateral patchy shadows or ground‐glass opacity in their lungs and negative RT-PCR for 2019‐nCoV. A total of 204 children were enrolled 2019-nCoV positive and negative. Seven 2019-nCoV positive patients were asymptomatic. Fever was mostly seen symptom in 2019-nCoV positive and negative patients at admission. White blood cell, neutrophil, monocyte, eosinophil, basophil and platelet count were significantly lower in 2019-nCoV positive patients than that of negative patients (p<0.05). While NLR, MLR, PLR and MPV/PC had no statistically difference, ELR and BLR ratios showed distinct significance between two groups (p<0.05). Hematologic indices haven’t been analyzed before in children with 2019-nCoV. WBC, ELR and BLR might be valuable ratios for the situation of inflammation in coronavirus infection.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol. 2020;75:2352-71.
2. Bangash MN, Patel J, Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 2020;5:529-30.
3. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033-34.
4. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95:834-47.
5. Yang Z, Zhang Z, Lin F, et al. Comparisons of neutrophil-, monocyte-, eosinophil-, and basophil- lymphocyte ratios among various systemic autoimmune rheumatic diseases. APMIS. 2017;125:863-71.
6. Gasparyan AY, Ayvazyan L, Mukanova U, et al The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med. 2019;39:345-57.
7. Vuong NL, Le Duyen HT, Lam PK, et al. C-reactive protein as a potential biomarker for disease progression in dengue: a multi-country observational study. BMC Med. 2020;18:35.
8. Fan BE, Chong VCL, Chan SSW, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020;95:131-4.
9. Guan WJ, Ni ZY, Hu Y, et al. China medical treatment expert group for Covid-19. clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708-20.
10. Türkiye Cumhuriyeti Sağlık Bakanlığı, COVID-19 numune alma el kitabı. Available online: http://hsgm.saglik.gov.tr/depo/kurumsal/plan-vefaaliyetler/ numune-almael kitabi.pdf
11. Oh GH, Chung SP, Park YS, et al. Mean platelet volume to platelet count ratio as a promising predictor of early mortality in severe sepsis. Shock. 2017;47:323–30.
12. Xia W, Shao J, Guo Y, et al. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatr Pulmonol. 2020;55:1169-74.
13. Vakili S, Savardashtaki A, Jamalnia S, et al. Laboratory findings of COVID-19 infection are conflicting in different age groups and pregnant women: a literature review. Arch Med Res. 2020;11:S0188-4409(20)30844-4.
14. Bai K, Liu W, Liu C, et al. Clinical Analysis of 25 COVID-19 Infections in Children. Pediatr Infect Dis J. 2020;39:e100-e103.
15. Du W, Yu J, Wang H, et al. Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China. Infection. 2020;48:445-52.
16. Wang D, Ju XL, Xie F, et al. Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China. Zhonghua Er Ke Za Zhi 2020;58:269-74.
17. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-13.
18. Roberts NJ Jr. Diverse and unexpected roles of human monocytes/ macrophages in the immune response to influenza virus. Viruses. 2020;12:379.
19. Chen J, Pan Y, Li G, et al. Distinguishing between COVID-19 and influenza during the early stages by measurement of peripheral blood parameters. J Med Virol. 2020;10:1002/jmv.26384.
20. Zhang JJ, Cao YY, Tan G, et al. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy. 2020;10. 1111/all.14496.
21. Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol .2020;146:1-7.
22. Dai J, Du Y, Gao J, et al. Difference in biomarkers between COVID-19 patients and other pulmonary infection patients. Infect Drug Resist. 2020;13:2609-15.
23. Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71:762-8.
24. Xiong X, Chua GT, Chi S, et al. Haematological and immunological data of Chinese children infected with coronavirus disease 2019. Data Brief. 2020;31:105953.
25. Qu R, Ling Y, Zhang YH, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020;92:1533-1541.
26. Djordjevic D, Rondovic G, Surbatovic M, et al. Neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume-to-platelet count ratio as biomarkers in critically Ill and injured patients: which ratio to choose to predict outcome and nature of bacteremia? Mediators Inflamm. 2018;2018:3758068.
27. Liu J, Liu Y, Xiang P, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. Transl Med. 2020;18:206.
28. Xia X, Wen M, Zhan S, et al. An increased neutrophil/lymphocyte ratio is an early warning signal of severe COVID-19. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:333-6.
29. Tuysuz ME, Dedemoglu M. High mean platelet volume to platelet count ratio as a predictor on poor outcomes after CABG. Gen Thorac Cardiovasc Surg. 2020;68:459-66.
30. Zhou MY, Xie XL, Peng YG, et al. From SARS to COVID-19: What we have learned about children infected with COVID-19. Int J Infect Dis. 2020;96:710-4.
31. Wang K, Zhang Z, Yu M, et al. 15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study. Intensive Care Med 2020;46:1472-4.

APA	Yilmaz S, Uzunoglu I, İNANDIKLIOĞLU N, Çağ Y, karaaslan a, Çetin C, AKIN Y (2022). The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection. , 214 - 219. 10.5455/medscience.2021.08.246
Chicago	Yilmaz Sema,Uzunoglu Ilknur,İNANDIKLIOĞLU NİHAL,Çağ Yakup,karaaslan ayşe,Çetin Ceren,AKIN YASEMIN The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection. (2022): 214 - 219. 10.5455/medscience.2021.08.246
MLA	Yilmaz Sema,Uzunoglu Ilknur,İNANDIKLIOĞLU NİHAL,Çağ Yakup,karaaslan ayşe,Çetin Ceren,AKIN YASEMIN The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection. , 2022, ss.214 - 219. 10.5455/medscience.2021.08.246
AMA	Yilmaz S,Uzunoglu I,İNANDIKLIOĞLU N,Çağ Y,karaaslan a,Çetin C,AKIN Y The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection. . 2022; 214 - 219. 10.5455/medscience.2021.08.246
Vancouver	Yilmaz S,Uzunoglu I,İNANDIKLIOĞLU N,Çağ Y,karaaslan a,Çetin C,AKIN Y The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection. . 2022; 214 - 219. 10.5455/medscience.2021.08.246
IEEE	Yilmaz S,Uzunoglu I,İNANDIKLIOĞLU N,Çağ Y,karaaslan a,Çetin C,AKIN Y "The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection." , ss.214 - 219, 2022. 10.5455/medscience.2021.08.246
ISNAD	Yilmaz, Sema vd. "The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection". (2022), 214-219. https://doi.org/10.5455/medscience.2021.08.246

APA	Yilmaz S, Uzunoglu I, İNANDIKLIOĞLU N, Çağ Y, karaaslan a, Çetin C, AKIN Y (2022). The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection. Medicine Science, 11(1), 214 - 219. 10.5455/medscience.2021.08.246
Chicago	Yilmaz Sema,Uzunoglu Ilknur,İNANDIKLIOĞLU NİHAL,Çağ Yakup,karaaslan ayşe,Çetin Ceren,AKIN YASEMIN The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection. Medicine Science 11, no.1 (2022): 214 - 219. 10.5455/medscience.2021.08.246
MLA	Yilmaz Sema,Uzunoglu Ilknur,İNANDIKLIOĞLU NİHAL,Çağ Yakup,karaaslan ayşe,Çetin Ceren,AKIN YASEMIN The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection. Medicine Science, vol.11, no.1, 2022, ss.214 - 219. 10.5455/medscience.2021.08.246
AMA	Yilmaz S,Uzunoglu I,İNANDIKLIOĞLU N,Çağ Y,karaaslan a,Çetin C,AKIN Y The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection. Medicine Science. 2022; 11(1): 214 - 219. 10.5455/medscience.2021.08.246
Vancouver	Yilmaz S,Uzunoglu I,İNANDIKLIOĞLU N,Çağ Y,karaaslan a,Çetin C,AKIN Y The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection. Medicine Science. 2022; 11(1): 214 - 219. 10.5455/medscience.2021.08.246
IEEE	Yilmaz S,Uzunoglu I,İNANDIKLIOĞLU N,Çağ Y,karaaslan a,Çetin C,AKIN Y "The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection." Medicine Science, 11, ss.214 - 219, 2022. 10.5455/medscience.2021.08.246
ISNAD	Yilmaz, Sema vd. "The evaluation of complete blood count ratios in children with 2019 novel coronavirus (2019‐ncov) infection". Medicine Science 11/1 (2022), 214-219. https://doi.org/10.5455/medscience.2021.08.246